38th ACS National Medicinal 91AV Symposium (NMCS 2024)

23 June 2024 11:00 - 26 June 2024 17:00, Seattle, WA , United States

Introduction

As per its tradition, this dynamic four day symposium aims to bring together medicinal chemists from across the country, and around the globe, working in the pharmaceutical industry, academia, regulatory agencies and private research institutions. The 2024 edition will be co-chaired by:

Rheem A. Totah, University of Washington
Patrick J. Burke, Enlaza Therapeutics

The Scientific Organizing Committee will arrange a distinguished lineup of speakers. For four days, Seattle will be the setting of a high-profile and international scientific meeting. The scientific program will be composed of six sessions presenting hot topics and emerging trends in medicinal chemistry and drug discovery. In addition, the MEDI Awards will be celebrated as part of a dedicated session.

Participants will be encouraged to submit abstracts to share their ideas and results. Several poster prizes will be awarded during the meeting.

Deadlines

Useful links

Speakers

Dr Maria-Jesus BLANCO ATAVISTIK BIO, Cambridge, United States
Dr Nicholas MEANWELL BRISTOL MYERS SQUIBB, Wallingford, United States
Prof. Richard B. SILVERMAN NORTHWESTERN UNIVERSITY, Evanston, United States
Prof. Michelle ARKIN UNIVERSITY OF CALIFORNIA, San Francisco, United States
Dr. Matthew HAYWARD MAGNET BIOMEDICINE, Boston , United States
Dr Kat KAYSER-BRICKER HALDA THERAPEUTICS, New Haven, United States
Dr Lingling SHEN NOVARTIS, Cambridge, United States
Dr Owen WALLACE MONTE ROSA THERAPEUTICS, Boston, United States
Prof. Ning ZHENG UNIVERSITY OF WASHINGTON, Seattle, United States
Prof. Rong HUANG PURDUE UNIVERSITY, West Lafayette, IN, United States
Prof. Jian JIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, New York, United States
Dr Christopher SMITH MIRATI THERAPEUTICS, San Diego, United States
Dr David DREWRY UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, Chapel Hill, United States
Dr Jennifer GOLDEN UNIVERSITY OF WISCONSIN, Madison, United States
Dr John A. MCCAULEY MERCK & CO. INC, Blue Bell, PA, United States
Dr Rebecca ABERGEL UNIVERSITY OF CALIFORNIA, Berkeley, United States
Dr Raffaele COLOMBO ZYMEWORKS, Vancouver, Canada
Dr Sharsti SANDALL SEAGEN, Bothell, United States
Dr Arvin DAR MEMORIAL SLOAN KETTERING CANCER CENTER, New York, United States
Dr John TOKARSKI BRISTOL MYERS SQUIBB, New York, United States
Dr Angela TOMS NIMBUS THERAPEUTICS, INC., Cambridge, United States
Dr Bernd KUHN F. HOFFMANN-LA ROCHE, Basel, Switzerland
Dr Veerabahu SHANMUGASUNDARAM BRISTOL MYERS SQUIBB, CAMBRIDGE, United States
Prof. Peter TONGE STONY BROOK UNIVERSITY, Stony Brook, United States
Prof. Marcey WATERS UNIVERSITY OF NORTH CAROLINA , Chapel Hill, United States
Dr David WEINSTEIN VIVIDION THERAPEUTICS, San Diego, United States
Dr Gaurav BHARDWAJ UNIVERSITY OF WASHINGTON, Seattle, United States
Dr Gavin HIRST ATOMWISE, San Francisco, United States
Dr Jennifer KNIGHT SCHRODINGER, New York, United States
Dr Mark MURCKO DISRUPTIVE BIOMEDICAL, LLC, Holliston, United States
Dr Pat WALTERS RELAY THERAPEUTICS, Cambridge, United States
Dr Matt WELBORN ENTOS, INC., La Jolla, United States

Sponsorship & supporting organisations

Venue

Sheraton Grand Seattle

Sheraton Grand Seattle, 1400 6th Avenue, Seattle, WA , 98101, United States

Useful links

Committee

Contact information

91AV

Share: